| Brand name |
Cerdelga
|
|---|---|
| المخاطر |
Drug-drug interaction: Use with CYP2D6 and/or CYP3A inhibitors, strong CYP3A inducers, P-gp or CYP2D6 substrates, Use of eliglustat in patients who are CYP2D6 indeterminate metabolizers or non-genotyped patients, Off label use in Gaucher disease type 2 and 3. |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Thu 25 Jun 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Government websites use the protocol. HTTPS for encryption and security.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.